Donor Lymphocytes: Clinical Trials

2 trials of Donor Lymphocytes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 22Completed 2

Follow Donor Lymphocytes: new trials by email Literature Review of Donor Lymphocytes trials Research Report on Donor Lymphocytes

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
WT1 Peptide-Pulsed Dendritic Cells, Donor Lymphocytes, IL-4 - Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL)
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)102008-02-222017-04-12
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer
total-body irradiation, fludarabine phosphate, cyclosporine - Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center212000-05-012020-01-21

Conditions studied

Hodgkin Disease (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Carcinoma, Renal Cell (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Hematologic Neoplasms (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Immunoglobulin Light-chain Amyloidosis (1)  ·  Intraocular Lymphoma (1)  ·  Leukemia (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Large Granular Lymphocytic (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

David Maloney (1)  ·  Terry J Fry, M.D. (1)

Results publications

PMID 32499241

NIH funding

P01CA078902 (1), P30CA015704 (1)